Related Experiment Video
Updated: Jul 27, 2025
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Treatment Process of Primary Prostate Leiomyosarcoma: A Rare Case Report
Denis Cetin1, Mustafa Murat Mıdık1, Mustafa Mustafayev1
1Department of Internal Medicine, School of Medicine, Ege University, 35100, Bornova, Izmir, Turkey.
Abstract:
Prostate sarcoma is an extremely rare malignancy that accounts for only %0.1 of all neoplasms of the prostate gland. Primary prostate leiomyosarcoma (PLSOP) is the most common subtype in adults. Due to the fact that it is an extremely rare malignancy, case reports have been reported frequently and several publications in the form of case series. The number of case reports in the world is less than 200. Our opinion is that publishing such rare diseases and bringing them to the literature will have positive benefits both scientifically and for the patients. We present a patient with PLSOP and discuss the clinical, diagnostic and therapeutic aspects of this rare malignancy. Keywords: Prostate, Leiomyosarcoma, Cancer, Prognosis.
